Valdoxan is a medication containing Agomelatine 25mg formulated as film-coated tablets, indicated for treating depression in adults. Additionally, Valdoxan 25mg is contraindicated in people with agomelatine allergy, patients with liver failure, or patients currently taking fluvoxamine or ciprofloxacin.

Depression is one of the most common mental health conditions worldwide, affecting over 280 million people (WHO, 2023). Despite its prevalence, it remains widely misunderstood.